Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26F1Y65
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,665
Award facts
- Contract value 100% obligated
- $18,665.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,665.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) Pen 40 mg/0.4 mL on January 29, 2026, with completion expected by January 30, 2026. This delivery order was issued without a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc., and performed the work at its corporate office location in Conshohocken, PA. The award is structured as a delivery order under a larger vehicle, reflecting the company's ongoing role as a critical supplier of pharmaceutical products to federal military and veteran healthcare systems.
This delivery order likely derives from AmerisourceBergen's substantial Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2026, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers specialty medications, brand-name and generic drugs, and related medical commodities across multiple therapeutic domains. AmerisourceBergen's demonstrated capability to efficiently fulfill federal medical procurement requirements through open competition, combined with its extensive portfolio of pharmaceutical product deliveries to the Defense Logistics Agency, underscores the company's strategic importance in the federal medical supply chain supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F1Y65?
SPE2DR26F1Y65 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F1Y65 worth?
The government has obligated $18,665 on SPE2DR26F1Y65.
Is contract SPE2DR26F1Y65 an order under another contract?
Yes. SPE2DR26F1Y65 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1Y65 competed?
The extent of competition for SPE2DR26F1Y65 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award